|
Volumn 48, Issue 2, 2000, Pages 151-160
|
Management of atypical and malignant meningiomas: Role of high-dose, 3D-conformal radiation therapy
a,b,c d a a a a a b |
Author keywords
Atypical meningioma; Brain neoplasm; Charged particle therapy; Malignant meningioma; Proton radiation therapy
|
Indexed keywords
COBALT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BRAIN BIOPSY;
BRAIN NECROSIS;
BRAIN SURGERY;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSIMETRY;
FEMALE;
HIGH RISK POPULATION;
HUMAN;
HUMAN TISSUE;
MALE;
MALIGNANT MENINGIOMA;
MENINGIOMA;
METASTASIS;
PHOTON;
RADIATION DOSE DISTRIBUTION;
RADIATION INJURY;
RECURRENCE RISK;
SURVIVAL RATE;
TARGET CELL;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANIMALS;
CHILD;
COMBINED MODALITY THERAPY;
CRANIAL IRRADIATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LIFE TABLES;
MALE;
MENINGEAL NEOPLASMS;
MENINGIOMA;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
PHOTONS;
PROPORTIONAL HAZARDS MODELS;
PROTONS;
RADIATION INJURIES;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, HIGH-ENERGY;
RETROSPECTIVE STUDIES;
SALVAGE THERAPY;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0033772910
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006434124794 Document Type: Article |
Times cited : (297)
|
References (25)
|